Intended for healthcare professionals

Rapid response to:

Editor's Choice

Covid 19: Hope is being eclipsed by deep frustration

BMJ 2021; 372 doi: (Published 21 January 2021) Cite this as: BMJ 2021;372:n171

Read our latest coverage of the coronavirus outbreak

Rapid Response:

Production of the vaccine Soberana 02 in Cuba.

Dear Editor

The Cuban government will produce 100 million doses of its vaccine, Soberana 02, against the new coronavirus this year in order to respond to its own demand and those of other countries. The 100 million doses planned would be only from Soverana 02 and there are already several countries interested in acquiring it, such as Vietnam, Iran and Venezuela, among others, and with those which the island has collaboration agreements, including Pakistan and India.

In the coming weeks, vaccination will be extended to 150,000 people on the island, on the way to mass immunization, and a test will be carried out in February to protect children with Soverana 02.

Despite being a small country, Cuba has a developed scientific center that produces almost all the vaccines it needs and state-of-the-art medicines.

Cuba's strategy to commercialize the vaccine has a combination of humanity and health impact and the need for our system to support, financially, the production of vaccine and drugs for the country.

The antigen is safe since it does not contain the live virus but parts of it, so its placement generates immunity, but it does not cause major reactions and, therefore, it does not require extra refrigeration, like other candidates in the world.

Cuba is going to be one of the first countries in the world to vaccinate all its inhabitants if not the first; during this year we will all be vaccinated.

Competing interests: No competing interests

24 January 2021
MSc. Ihosvany Castellanos Santos
Asociate Professor
Francisco Javier Zerquera 15. Trinidad. Cuba.